<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05121311</url>
  </required_header>
  <id_info>
    <org_study_id>507/2021B02</org_study_id>
    <nct_id>NCT05121311</nct_id>
  </id_info>
  <brief_title>Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm</brief_title>
  <acronym>Bili-PrediX1</acronym>
  <official_title>Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm - Prospective Observational Study -</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NeoPredix AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Center for Pediatric Clinical Studies (CPCS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NeoPredix AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Due to actual standard of neonatal care bilirubin is monitored in neonates several times&#xD;
      after birth to avoid hyperbilirubinemia. As the peak is often one or two days after discharge&#xD;
      from hospital a more precise predication than the actual one is desirable to avoid needlessly&#xD;
      follow-ups. The precision of an algorithm to predict bilirubin values 24-48h into the future&#xD;
      is evaluated in this study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neonatal jaundice is common and mostly transient without need for intervention. To identify&#xD;
      infants at risk of bilirubin toxicity, bilirubin is measured several times after birth and&#xD;
      before discharge home. As the peak bilirubin concentrations are reached at days 4-6 after&#xD;
      birth, and most infants are discharged home around 48 hours after birth, parents are often&#xD;
      asked to return to hospital one or two days after discharge with their newborn baby to have&#xD;
      the bilirubin value checked in order to prevent that hyperbilirubinemia requiring treatment&#xD;
      is not missed. A precise prediction of the course of bilirubin values based on the&#xD;
      measurements done during the initial hospital stay after birth would be desirable to avoid&#xD;
      unnecessary follow ups (both for the families and the health care system).&#xD;
&#xD;
      This study aims to evaluate the precision of the NeoprediX B1 algorithm. This algorithm&#xD;
      predicts bilirubin values 24-48h into the future based on preceding values and some clinical&#xD;
      variables. Five different scenarios will be explored, differing in the type, number and&#xD;
      timepoints of measurements used for the prediction as well as the timepoint that is to be&#xD;
      predicted.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 9, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Precision of predicted bilirubin value</measure>
    <time_frame>8 hours to 144 hours after birth</time_frame>
    <description>Precision of the bilirubin value calculated by the NeoprediX B1 algorithm compared to the value measured by the center</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Newborn Jaundice</condition>
  <arm_group>
    <arm_group_label>Newborns under bilirubin monitoring</arm_group_label>
    <description>Bilirubin monitoring according to standard of care of the participating center</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>NeoprediX B1 algorithm</intervention_name>
    <description>Re-assessement of bilirubin measurements done according to standard of care of the participating center by the NeoprediX B1 algorithm</description>
    <arm_group_label>Newborns under bilirubin monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Newborn infants&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Newborn infant&#xD;
&#xD;
          -  gestational age at birth ≥ 34+0/7 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Birth weight &lt; 1500g&#xD;
&#xD;
          -  Gestational age at birth &gt; 42+6/7 weeks&#xD;
&#xD;
          -  Genetically defined syndrome&#xD;
&#xD;
          -  Severe congenital malformation adversely affecting life expectancy or admission for a&#xD;
             priori planned palliative care&#xD;
&#xD;
          -  Parents not fluent in German&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>72 Hours</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Axel Franz, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Children's Hospital Tübingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Axel Franz, Prof.</last_name>
    <phone>49-7071-2983791</phone>
    <email>axel.franz@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sarah Besch, Dr.</last_name>
    <phone>49-7071-2982211</phone>
    <email>sarah.besch@med.uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KUNO Kinderklinik St. Hedwig</name>
      <address>
        <city>Regensburg</city>
        <zip>93049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sven Wellmann, Prof.</last_name>
      <phone>49-941-36998</phone>
      <email>sven.wellmann@barmherzige-regensburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Holger Michel, Dr.</last_name>
      <phone>49-941-36998</phone>
      <email>holger.michel@barmherzige-regensburg.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Franz, Prof.</last_name>
      <phone>49-7071-2983791</phone>
      <email>axel.franz@med.uni-tuebingen.de</email>
    </contact>
    <contact_backup>
      <last_name>Sarah Besch, Dr.</last_name>
      <phone>49-7071-2982211</phone>
      <email>sarah.besch@med.uni-tuebingen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 18, 2021</study_first_submitted>
  <study_first_submitted_qc>November 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>newborn jaundice</keyword>
  <keyword>Hyperbilirubinaemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperbilirubinemia, Neonatal</mesh_term>
    <mesh_term>Jaundice, Neonatal</mesh_term>
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Hyperbilirubinemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

